Reference : Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine...
Scientific journals : Article
Human health sciences : Gastroenterology & hepatology
Human health sciences : Surgery
Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC).
Dahlqvist, G. [> >]
Moreno, C. [> >]
Starkel, P. [> >]
Detry, Olivier mailto [Université de Liège - ULiège > Département des sciences cliniques > Pathologie chirurgicale abdominale et endocrinienne >]
Coubeau, L. [> >]
Jochmans, I. [> >]
Acta Gastro-Enterologica Belgica
Yes (verified by ORBi)
[en] Advisory Committees ; Belgium ; Carcinoma, Hepatocellular ; Humans ; Intestines ; Liver Neoplasms ; Liver Transplantation ; Alcoholic hepatitis ; HCC ; HCV ; Liver transplantation ; colorectal cancer metastasis ; machine perfusion ; cancer ; hepatocarcinoma
[en] Liver transplantation (LT) remains the only curative option for patients suffering from end-stage liver disease, acute liver failure and selected hepatocellular carcinomas and access to the LT-waiting list is limited to certain strict indications. However, LT has shown survival advantages for patients in certain indications such as acute alcoholic hepatitis, hepatocellular carcinoma outside Milan criteria and colorectal cancer metastases. These newer indications increase the pressure in an already difficult context of organ shortage. Strategies to increase the transplantable organ pool are therefore needed. We will discuss here the use of HCV positive grafts as the use of normothermic isolated liver perfusion. Belgian Liver Intestine Advisory Committee (BeLIAC) from the Belgian Transplant Society (BTS) aims to guarantee the balance between the new indications and the available resources.
© Acta Gastro-Enterologica Belgica.

File(s) associated to this reference

Fulltext file(s):

Open access
15-Dahlqvist.pdfPublisher postprint638.25 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.